PIER MARIA FORNASARI
2019-03-01

FDA cautions patients, providers about using robotically-assisted surgical devices for mastectomy and other cancer-related surgeries

March 1 2019 P.M. Fornasari “Certain patients with cancer may require surgical procedures to treat or prevent the spread of cancer in their body. These procedures are often associated with improved survival outcomes for these patients. However, today we are warning patients and providers that the use of robotically-assisted surgical devices for any cancer-related surgery

Read More

No Comments InROBOTIC SURGERY
PIER MARIA FORNASARI
2019-02-28

A new Italian manifesto against racism Support it

As an interdisciplinary team that includes biological and cultural anthropologists, we have issued a manifesto for education in human diversity and unity (see go.nature.com/2sc1eoj). This aims to counteract our country’s current surge in racism and intolerance, and will help students to develop a more open attitude (see go.nature.com/2xch3ns). The manifesto opposes the racist manifesto of 1938, originally signed by

Read More

6 comments InHOME
PIER MARIA FORNASARI
2019-02-27

Unique augmented reality concept for image-guided minimally invasive therapies

February 27 2019 P.M.Fornasari At the MWC Barcelona, one of the largest mobile events in the world, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology today unveiled a unique mixed reality concept developed together with Microsoft Corp. (NASDAQ: MSFT) for the operating room of the future. Based on the state-of-the-art technologies

Read More

7 comments InAUGMENTED REALITY
PIER MARIA FORNASARI
2019-02-27

Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity

Alzheimer’s Disease (AD) represents a major and rapidly growing burden to the healthcare ecosystem. In the USA alone, some 5 million people suffer from the disease that costs the managed healthcare system in excess of $250 billion. Currently the sixth leading cause of death, AD prevalence has increased by 89% since 2000, underscoring the need

Read More

No Comments InDIGITAL HEALTH
PIER MARIA FORNASARI
2019-02-26

Reprogrammed’ stem cells to treat spinal-cord injuries for the first time

Approval from Japanese regulators means that trials of induced pluripotent stem cells can begin later this year. Scientists in Japan now have permission to inject ‘reprogrammed’ stem cells into people with spinal-cord injuries. An upcoming trial will mark the first time that induced pluripotent stem (iPS) cells have been used to treat spinal-cord injuries, after

Read More

One comment IniPS cells
PIER MARIA FORNASARI
2019-02-25

New Smart Garments Powered by Body Heat

Researchers have developed new smart fabric coated with polymer that can provide electricity for small, wearable devices. February 25, 2019 by P.M.Fornasari Many wearable biosensors, data transmitters and similar tech advances for personalized health monitoring have now been “creatively miniaturized,” says materials chemist Trisha Andrew at the University of Massachusetts Amherst, but they require a

Read More

No Comments InWEARABLES
PIER MARIA FORNASARI
2019-02-25

Chronic Low Back Pain Study Results Indicate Benefit With Tanezumab

Februray 25, 2019 P.M. Fornasari Tanezumab, an investigational subcutaneously-administered, non-opioid treatment, may benefit patients with moderate to severe chronic low back pain (CLBP), according to top-line results from a Phase 3 study. Study A4091059, a double-blind, placebo- and active-controlled study, included patients with moderate to severe CLBP who had persistent low back pain for more

Read More

No Comments InBIOLOGICS
PIER MARIA FORNASARI
2019-02-25

ASIPP Releases Guidelines for Use of Biologics in Management of Low Back Pain

February 25, 2019 P.M. Fornasari A task force of regenerative medicine experts established by the American Society of Interventional Pain Physicians (ASIPP) has formulated new guidelines for the safe and effective use of biologics in the management of low back pain. The guidelines, published in Pain Physician, are based on a review of the literature on the

Read More

No Comments InBIOLOGICS
PIER MARIA FORNASARI
2019-02-23

FDA Encourages Development of Regenerative Medicines

The agency clarified the process for development programs for regenerative medicine therapies. Feb 20, 2019 By Pier Maria Fornasari FDA provided further details in February 2019 on how manufacturers may use expedited development programs for regenerative medicine therapies, clarifying that the category includes gene and Chimeric antigen receptor T cells (CAR-T) therapies, as well as cellular

Read More

No Comments InREGENERATIVE MEDICINE